CIK 0001520262
- Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981007018
- Phone
- +353 17728000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $697,937
- in 4 filings, $698K under 10b5-1 plans
Net −$697,937. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-03 | Jackson Blair Curtis EVP, Chief Operating Officer | Exercise or conversion | +34,503 | $18.11 | $625K | 102,657 |
| 2021-05-03 | Jackson Blair Curtis EVP, Chief Operating Officer | Sale | −34,503 | $22.18 | $765K | 68,154 |
| 2021-05-03 | Jackson Blair Curtis EVP, Chief Operating Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −34,503 | 0 | ||
| 2021-04-19 | DIXON WENDY L Director | Exercise or conversion | +25,000 | $14.60 | $365K | 61,600 |
| 2021-04-19 | DIXON WENDY L Director | Sale | −25,000 | $20.00 | $500K | 36,600 |
| 2021-04-19 | DIXON WENDY L Director | Exercise or conversion · Non Qualified Stock Option (Right to Buy) | −25,000 | 0 | ||
| 2021-04-19 | Brown Iain Michael SVP, Chief Financial Officer | Exercise or conversion | +34,792 | $18.11 | $630K | 83,154 |
| 2021-04-19 | Brown Iain Michael SVP, Chief Financial Officer | Sale | −34,792 | $20.00 | $696K | 48,362 |
| 2021-04-19 | Brown Iain Michael SVP, Chief Financial Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −34,792 | 0 | ||
| 2021-04-16 | Brown Iain Michael SVP, Chief Financial Officer | Exercise or conversion | +208 | $18.11 | $4K | 48,570 |
| 2021-04-16 | Brown Iain Michael SVP, Chief Financial Officer | Sale | −208 | $19.99 | $4K | 48,362 |
| 2021-04-16 | Brown Iain Michael SVP, Chief Financial Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −208 | 34,792 | ||
| 2021-04-15 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Sale | −28,920 | $19.72 | $570K | 0 |
| 2021-02-22 | POPS RICHARD F Director and CEO, Alkermes plc | Grant or award · Employee Stock Option (Right to Buy) | +342,187 | 342,187 | ||
| 2021-02-22 | Nichols Christian Todd SVP, Chief Commercial Officer | Grant or award · Employee Stock Option (Right to Buy) | +113,754 | 113,754 | ||
| 2021-02-22 | Nichols Christian Todd SVP, Chief Commercial Officer | Grant or award · Restricted Stock Unit Award | +27,877 | 27,877 | ||
| 2021-02-22 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Grant or award · Employee Stock Option (Right to Buy) | +90,487 | 90,487 | ||
| 2021-02-22 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Grant or award · Restricted Stock Unit Award | +22,175 | 22,175 | ||
| 2021-02-22 | Jackson Blair Curtis EVP, Chief Operating Officer | Grant or award · Employee Stock Option (Right to Buy) | +155,119 | 155,119 | ||
| 2021-02-22 | Jackson Blair Curtis EVP, Chief Operating Officer | Grant or award · Restricted Stock Unit Award | +38,014 | 38,014 |
Page 65 of 75 · 1,492 trades